Clinical Trial Update: Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures [NA]

View source ↗

Summary

A clinical trial comparing 19- and 22-gauge needles for core tissue procurement during EUS-guided procedures in pancreatic cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: AdventHealth | Conditions: Pancreatic Cancer | NA | Status: WITHDRAWN